07.19.22
Johnson & Johnson, maker of Neutrogena and Aveeno skincare, has released results for the second quarter of 2022.
Worldwide corporate revenues in Q2 rose 3.0% to $24.0 billion.
J&J’s worldwide consumer health business sales fell 1.3% to $3.8 billion. However, sales rose 2.3% operationally when factoring in the impact of translational currency, said J&J. Major contributors to growth included upper respiratory and analgesic products in the international market and in digestive health products, as well as Neutrogena in international skin health/beauty. Additional drivers included Lubriderm and Le Petit Marseillas.
“Our solid second quarter results across Johnson & Johnson reflect the strength and resilience of our Company’s market leadership in the midst of macroeconomic challenges,” said Joaquin Duato, CEO. “I am continually energized by the focus and passion of my Johnson & Johnson colleagues and their dedication toward delivering transformative healthcare solutions to patients and consumers around the world.”
Johnson & Johnson is ranked No. 6 in Happi's 2022 Top 50 Report.
Worldwide corporate revenues in Q2 rose 3.0% to $24.0 billion.
J&J’s worldwide consumer health business sales fell 1.3% to $3.8 billion. However, sales rose 2.3% operationally when factoring in the impact of translational currency, said J&J. Major contributors to growth included upper respiratory and analgesic products in the international market and in digestive health products, as well as Neutrogena in international skin health/beauty. Additional drivers included Lubriderm and Le Petit Marseillas.
“Our solid second quarter results across Johnson & Johnson reflect the strength and resilience of our Company’s market leadership in the midst of macroeconomic challenges,” said Joaquin Duato, CEO. “I am continually energized by the focus and passion of my Johnson & Johnson colleagues and their dedication toward delivering transformative healthcare solutions to patients and consumers around the world.”
Johnson & Johnson is ranked No. 6 in Happi's 2022 Top 50 Report.